In this retrospective study, Samson and colleagues present excellent results (2% neurologic event rate, 0.7% mortality, and no clinically apparent myocardial infarctions) in 147 consecutive contralateral carotid occlusion patients, who underwent carotid endarterectomy (CEA) without shunting. They attribute their success to the use of general anesthesia with careful maintenance of systolic blood pressure above 130 mm Hg. Their results add fuel to the controversies over neurologic risk in contralateral occlusion patients and over the role of shunting. While provocative, the study is not definitive. It suffers from the weaknesses inherent in retrospective analyses. The credibility of the outcome data suffers from the absence of independent routine pre- and post-CEA neurologic assessment and of a set protocol for post-CEA brain imaging. It is almost certain that there were more perioperative strokes than they report, though these events were clinically silent or subtle. Furthermore, given the authors' use of phenylephrine-induced hypertension as a means of cerebral protection, their failure to routinely monitor postoperative cardiac enzymes represents a missed opportunity to confirm the safety of their protocol. Theoretically, at least, the routine use of vasopressors will add to the hemodynamic stress of the surgery, thereby raising the risk of perioperative cardiac morbidity. Despite these shortcomings, this report confirms four facts: (1) Well-trained surgeons, working with detail-oriented anesthesiologists and adhering to well-defined management protocols, can achieve excellent results with CEA even in putatively high-risk patients. (2) CEA patients with contralateral occlusion are not necessarily at high neurologic risk. (3) The argument that contralateral occlusion represents an indication for carotid stenting is specious. (4) Contralateral occlusion is not an absolute indication for shunt placement during CEA. The report does not establish the superiority of the authors' practices, but it does establish their management protocol as one acceptable approach to the management of CEA patients with contralateral occlusion. Those who achieve excellent results in this patient population with carotid stenting or with CEA with shunting are not likely to be converted by these data, but now have another standard against which to measure their outcomes. Controversy over the risk associated with contralateral occlusion and the role of shunting will continue. In the face of ongoing controversy, surgeons will continue to adopt and report those practices that provide optimal results for their patients. Contralateral carotid artery occlusion is not a contraindication to carotid endarterectomy even if shunts are not routinely usedJournal of Vascular SurgeryVol. 58Issue 4PreviewAlthough controversial, carotid artery stenting (CAS) has been proposed as being safer than carotid endarterectomy (CEA) for patients with a contralateral internal carotid occlusion (CCO). Arguably, with a CCO, CAS should be even safer than CEA if a shunt is not used. Accordingly, we reviewed our experience with 2183 CEAs performed routinely without a shunt to evaluate the risk of CEA performed in a subset of 147 patients with a CCO. Full-Text PDF Open Archive
Read full abstract